Assessment of serum microRNA biomarkers for predicting reclassification of prostate cancer patients on active surveillance
The Journal of Urology Dec 22, 2017
Liu RSC, et al. - An investigation was conducted of the promising circulating miRNA biomarkers in order to speculate the reclassification of active surveillance patients. It was determined that the 3-miR score in combination with PSA served as a non-invasive biomarker panel with a high negative predictive value. This could assist in detecting active surveillance patients with truly indolent prostate cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
